Document and Entity Information
Document and Entity Information Document | Nov. 03, 2021 | Aug. 06, 2020 | Sep. 30, 2021 |
Cover [Abstract] | |||
Document Type | 8-K | ||
Amendment Flag | false | ||
Document Period End Date | Nov. 3, 2021 | ||
Entity Registrant Name | AMNEAL PHARMACEUTICALS, INC. | ||
Entity Central Index Key | 0001723128 | ||
Entity Emerging Growth Company | false | ||
Entity File Number | 001-38485 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 32-0546926 | ||
Entity Address, Address Line One | 400 Crossing Blvd | ||
Entity Address, City or Town | Bridgewater | ||
Entity Address, State or Province | NJ | ||
Entity Address, Postal Zip Code | 08807 | ||
City Area Code | 908 | ||
Local Phone Number | 947-3120 | ||
Written Communications | false | ||
Soliciting Material | false | ||
Pre-commencement Tender Offer | false | ||
Pre-commencement Issuer Tender Offer | false | ||
Title of 12(b) Security | Class A Common Stock, par value $0.01 per share | ||
Trading Symbol | AMRX | ||
Security Exchange Name | NYSE |